Annual Shareholders Equity
$249.28 M
+$18.82 M+8.16%
31 December 2023
Summary:
Verona Pharma annual stockholders equity is currently $249.28 million, with the most recent change of +$18.82 million (+8.16%) on 31 December 2023. During the last 3 years, it has risen by +$64.43 million (+34.85%). VRNA annual shareholders equity is now at all-time high.VRNA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$130.49 M
-$37.78 M-22.45%
30 September 2024
Summary:
Verona Pharma quarterly stockholders equity is currently $130.49 million, with the most recent change of -$37.78 million (-22.45%) on 30 September 2024. Over the past year, it has dropped by -$133.04 million (-50.48%). VRNA quarterly shareholders equity is now -52.85% below its all-time high of $276.75 million, reached on 31 March 2023.VRNA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.2% | -50.5% |
3 y3 years | +34.9% | -22.4% |
5 y5 years | +209.8% | +163.5% |
VRNA Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +68.4% | -52.9% | +17.7% |
5 y | 5 years | at high | +483.2% | -52.9% | +452.4% |
alltime | all time | at high | >+9999.0% | -52.9% | +7808.1% |
Verona Pharma Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $130.49 M(-22.5%) |
June 2024 | - | $168.27 M(-25.2%) |
Mar 2024 | - | $224.99 M(-9.7%) |
Dec 2023 | $249.28 M(+8.2%) | $249.28 M(-5.4%) |
Sept 2023 | - | $263.53 M(-3.5%) |
June 2023 | - | $273.09 M(-1.3%) |
Mar 2023 | - | $276.75 M(+20.1%) |
Dec 2022 | $230.47 M(+55.7%) | $230.47 M(-3.0%) |
Sept 2022 | - | $237.49 M(+114.2%) |
June 2022 | - | $110.88 M(-12.2%) |
Mar 2022 | - | $126.31 M(-14.7%) |
Dec 2021 | $148.00 M(-19.9%) | $148.00 M(-12.0%) |
Sept 2021 | - | $168.20 M(+8.9%) |
June 2021 | - | $154.40 M(-10.4%) |
Mar 2021 | - | $172.41 M(-6.7%) |
Dec 2020 | $184.85 M(+332.5%) | $184.85 M(-6.5%) |
Sept 2020 | - | $197.72 M(+736.9%) |
June 2020 | - | $23.62 M(-26.0%) |
Mar 2020 | - | $31.94 M(-25.3%) |
Dec 2019 | $42.74 M(-46.9%) | $42.74 M(-13.7%) |
Sept 2019 | - | $49.52 M(-21.6%) |
June 2019 | - | $63.14 M(-16.7%) |
Mar 2019 | - | $75.80 M(-5.8%) |
Dec 2018 | $80.47 M(-25.5%) | $80.47 M(-5.3%) |
Sept 2018 | - | $84.95 M(-2.7%) |
June 2018 | - | $87.35 M(-5.1%) |
Mar 2018 | - | $92.01 M(-14.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $107.95 M(+153.8%) | $107.95 M(-5.4%) |
Sept 2017 | - | $114.17 M(-5.8%) |
June 2017 | - | $121.23 M(+185.1%) |
Dec 2016 | $42.53 M(+428.3%) | $42.53 M(+664.6%) |
June 2016 | - | $5.56 M(-30.9%) |
Dec 2015 | $8.05 M(-59.0%) | $8.05 M(-44.2%) |
June 2015 | - | $14.43 M(-26.5%) |
Dec 2014 | $19.62 M(+475.3%) | $19.62 M(-16.9%) |
June 2014 | - | $23.60 M(+592.2%) |
Dec 2013 | $3.41 M(-18.9%) | $3.41 M(-14.6%) |
June 2013 | - | $3.99 M(-5.1%) |
Dec 2012 | $4.21 M(-33.1%) | $4.21 M(-33.6%) |
June 2012 | - | $6.34 M(+0.7%) |
Dec 2011 | $6.29 M(+18.1%) | $6.29 M(+48.3%) |
June 2011 | - | $4.24 M(-20.4%) |
Dec 2010 | $5.33 M(-26.5%) | $5.33 M(-21.3%) |
June 2010 | - | $6.76 M(-6.7%) |
Dec 2009 | $7.25 M(+23.9%) | $7.25 M(+36.2%) |
June 2009 | - | $5.32 M(-9.0%) |
Dec 2008 | $5.85 M(+2.1%) | $5.85 M(-35.0%) |
June 2008 | - | $9.00 M(+57.1%) |
Dec 2007 | $5.73 M(-25.0%) | $5.73 M(-17.1%) |
June 2007 | - | $6.91 M(-9.5%) |
Dec 2006 | $7.64 M(+353.3%) | $7.64 M(+362.8%) |
June 2006 | - | $1.65 M(-2.0%) |
Dec 2005 | $1.68 M | $1.68 M(-5.6%) |
June 2005 | - | $1.78 M |
FAQ
- What is Verona Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Verona Pharma?
- What is Verona Pharma annual shareholders equity year-on-year change?
- What is Verona Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Verona Pharma?
- What is Verona Pharma quarterly shareholders equity year-on-year change?
What is Verona Pharma annual stockholders equity?
The current annual shareholders equity of VRNA is $249.28 M
What is the all time high annual shareholders equity for Verona Pharma?
Verona Pharma all-time high annual stockholders equity is $249.28 M
What is Verona Pharma annual shareholders equity year-on-year change?
Over the past year, VRNA annual stockholders equity has changed by +$18.82 M (+8.16%)
What is Verona Pharma quarterly stockholders equity?
The current quarterly shareholders equity of VRNA is $130.49 M
What is the all time high quarterly shareholders equity for Verona Pharma?
Verona Pharma all-time high quarterly stockholders equity is $276.75 M
What is Verona Pharma quarterly shareholders equity year-on-year change?
Over the past year, VRNA quarterly stockholders equity has changed by -$133.04 M (-50.48%)